DOCICAR: Cardiac Dysfunction in Cirrhosis

Cirrhosis Clinical Trial

Official title:

Cardiac Dysfunction in Cirrhosis: Cirrhotic Cardiomyopathy Evaluated by Dobutamin MRI.

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00250315
• Other study ID #: (KF) 01 270675
• Status: Completed
• Phase: Phase 3
• First received: November 4, 2005
• Last updated: October 31, 2007
• Start date: November 2005
• Est. completion date: October 2007

Study information

• Verified date: October 2007
• Source: Hvidovre University Hospital
• Contact: n/a
• Is FDA regulated: No
• Health authority: Denmark: Sundhedsstyrelsen
• Study type: Observational

Clinical Trial Summary

Patients with cirrhosis have a altered cardiac response to stress. This study evaluate the cardiac response by MRI during dobutamine stress. Hypothesis: impared increase in cardiac output, cardiac index, ejection fraction.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 0
• Est. completion date: October 2007
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: 18 Years to 75 Years

Eligibility

Inclusion Criteria:

• Non alkoholic cirrhosis

Exclusion Criteria:

• Coma hepaticum

• Primary cardiac diseases

Study Design

Time Perspective: Prospective

Related Conditions & MeSH terms

• Cardiomyopathies
• Cirrhosis
• Cirrhotic Cardiomyopathy
• Liver Cirrhosis

Intervention

Drug:
• Dobutamine

Locations

Country	Name	City	State
Denmark	Hvidovre University Hospital	Copenhagen	Hvidovre

Sponsors (1)

Lead Sponsor	Collaborator
Hvidovre University Hospital

Country where clinical trial is conducted

Denmark,